FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2099304911> ?p ?o ?g. }

• W2099304911 abstract "Bone marrow derived cellular therapies are an emerging approach to promoting therapeutic angiogenesis in ischemic cardiovascular disease. However, the percentage of regenerative cells in bone marrow mononuclear cells (BMMNCs) is small, and large amounts of BMMNCs are required. Ixmyelocel-T, an expanded autologous multicellular therapy, is manufactured from a small sample of bone marrow aspirate. Ixmyelocel-T contains expanded populations of mesenchymal stromal cells (MSCs) and M2-like macrophages, as well as many of the CD45+ cells found in the bone marrow. It is hypothesized that this expanded multi-cellular therapy would induce angiogenesis and endothelial repair.A rat model of hind limb ischemia was used to determine the effects of ixmyelocel-T on blood flow recovery. To further determine the effects on endothelial cells, ixmyelocel-T was co-cultured with human umbilical vein endothelial cells (HUVEC) in non-contacting Transwell® inserts.Co-culture of HUVECs with ixmyelocel-T resulted secretion of a variety of pro-angiogenic factors. HUVECs stimulated by ixmyelocel-T exhibited enhanced migration, proliferation, and branch formation. Ixmyelocel-T co-culture also resulted in increased endothelial nitric oxide synthase (eNOS) expression and nitric oxide (NO) production. In tumor necrosis factor alpha (TNFα)-stimulated HUVECs, ixmyelocel-T co-culture decreased apoptosis and reactive oxygen species generation, increased super oxide dismutase activity, and decreased nuclear factor kappa B (NFκB) activation. Treatment with ixmyelocel-T in a rat model of hind limb ischemia resulted in significantly increased blood flow perfusion and capillary density, gene expression and plasma levels of the anti-inflammatory cytokine interleukin (IL)-10, plasma nitrates, plasma platelet-derived growth factor (PDGF)-BB, vascular endothelial growth factor (VEGF) expression, and significantly decreased plasma thiobarbituric acid reactive substances (TBARS).This work demonstrates that ixmyelocel-T interacts with endothelial cells in a paracrine manner, resulting in angiogenesis and endothelial protection. This data suggests that ixmyelocel-T could be useful for promoting of angiogenesis and tissue repair in ischemic cardiovascular diseases. In conclusion, ixmyelocel-T therapy may provide a new aspect of therapeutic angiogenesis in this patient population where expanded populations of regenerative cells might be required." @default.
• W2099304911 created "2016-06-24" @default.
• W2099304911 creator A5018990140 @default.
• W2099304911 creator A5021928876 @default.
• W2099304911 creator A5030995197 @default.
• W2099304911 creator A5042685909 @default.
• W2099304911 creator A5079583715 @default.
• W2099304911 date "2015-03-13" @default.
• W2099304911 modified "2023-09-27" @default.
• W2099304911 title "Therapeutic potential of ixmyelocel-T, an expanded autologous multicellular therapy for treatment of ischemic cardiovascular diseases" @default.
• W2099304911 cites W1936275650 @default.
• W2099304911 cites W1964168680 @default.
• W2099304911 cites W1968254493 @default.
• W2099304911 cites W1972998985 @default.
• W2099304911 cites W1979323548 @default.
• W2099304911 cites W2005983726 @default.
• W2099304911 cites W2021870001 @default.
• W2099304911 cites W2030239024 @default.
• W2099304911 cites W2033665800 @default.
• W2099304911 cites W2045713940 @default.
• W2099304911 cites W2045716920 @default.
• W2099304911 cites W2049206418 @default.
• W2099304911 cites W2053303896 @default.
• W2099304911 cites W2053921558 @default.
• W2099304911 cites W2053995373 @default.
• W2099304911 cites W2056328458 @default.
• W2099304911 cites W2064202159 @default.
• W2099304911 cites W2073847471 @default.
• W2099304911 cites W2080052121 @default.
• W2099304911 cites W2083746078 @default.
• W2099304911 cites W2084686887 @default.
• W2099304911 cites W2086044130 @default.
• W2099304911 cites W2101250175 @default.
• W2099304911 cites W2101303978 @default.
• W2099304911 cites W2102367501 @default.
• W2099304911 cites W2107725221 @default.
• W2099304911 cites W2111322736 @default.
• W2099304911 cites W2114676398 @default.
• W2099304911 cites W2114715601 @default.
• W2099304911 cites W2123436033 @default.
• W2099304911 cites W2136834127 @default.
• W2099304911 cites W2139851192 @default.
• W2099304911 cites W2152260995 @default.
• W2099304911 cites W2156879778 @default.
• W2099304911 cites W2161765882 @default.
• W2099304911 cites W2166005447 @default.
• W2099304911 cites W2171445986 @default.
• W2099304911 cites W2338111751 @default.
• W2099304911 cites W2412548691 @default.
• W2099304911 doi "https://doi.org/10.1186/s13287-015-0007-3" @default.
• W2099304911 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4413547" @default.
• W2099304911 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25889271" @default.
• W2099304911 hasPublicationYear "2015" @default.
• W2099304911 type Work @default.
• W2099304911 sameAs 2099304911 @default.
• W2099304911 citedByCount "11" @default.
• W2099304911 countsByYear W20993049112016 @default.
• W2099304911 countsByYear W20993049112017 @default.
• W2099304911 countsByYear W20993049112018 @default.
• W2099304911 countsByYear W20993049112019 @default.
• W2099304911 countsByYear W20993049112020 @default.
• W2099304911 countsByYear W20993049112021 @default.
• W2099304911 countsByYear W20993049112022 @default.
• W2099304911 crossrefType "journal-article" @default.
• W2099304911 hasAuthorship W2099304911A5018990140 @default.
• W2099304911 hasAuthorship W2099304911A5021928876 @default.
• W2099304911 hasAuthorship W2099304911A5030995197 @default.
• W2099304911 hasAuthorship W2099304911A5042685909 @default.
• W2099304911 hasAuthorship W2099304911A5079583715 @default.
• W2099304911 hasBestOaLocation W20993049111 @default.
• W2099304911 hasConcept C10882517 @default.
• W2099304911 hasConcept C142724271 @default.
• W2099304911 hasConcept C16930146 @default.
• W2099304911 hasConcept C198826908 @default.
• W2099304911 hasConcept C202751555 @default.
• W2099304911 hasConcept C203014093 @default.
• W2099304911 hasConcept C2777411675 @default.
• W2099304911 hasConcept C2778271429 @default.
• W2099304911 hasConcept C2778690821 @default.
• W2099304911 hasConcept C2780007613 @default.
• W2099304911 hasConcept C2780394083 @default.
• W2099304911 hasConcept C2781188250 @default.
• W2099304911 hasConcept C28328180 @default.
• W2099304911 hasConcept C502942594 @default.
• W2099304911 hasConcept C55493867 @default.
• W2099304911 hasConcept C71924100 @default.
• W2099304911 hasConcept C86803240 @default.
• W2099304911 hasConcept C95444343 @default.
• W2099304911 hasConceptScore W2099304911C10882517 @default.
• W2099304911 hasConceptScore W2099304911C142724271 @default.
• W2099304911 hasConceptScore W2099304911C16930146 @default.
• W2099304911 hasConceptScore W2099304911C198826908 @default.
• W2099304911 hasConceptScore W2099304911C202751555 @default.
• W2099304911 hasConceptScore W2099304911C203014093 @default.
• W2099304911 hasConceptScore W2099304911C2777411675 @default.
• W2099304911 hasConceptScore W2099304911C2778271429 @default.
• W2099304911 hasConceptScore W2099304911C2778690821 @default.
• W2099304911 hasConceptScore W2099304911C2780007613 @default.
• W2099304911 hasConceptScore W2099304911C2780394083 @default.
• W2099304911 hasConceptScore W2099304911C2781188250 @default.

• next